medigraphic.com
SPANISH

Revista Cubana de Farmacia

ISSN 1561-2988 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 1

<< Back Next >>

Rev Cubana Farm 2012; 46 (1)

Quantification of glibenclamide in cleaning samples of pharmaceutical equipment through high performance liquid chromatography

Baeza FAN, Díaz ÁEE, Martínez ACN
Full text How to cite this article

Language: Spanish
References: 13
Page: 29-39
PDF size: 103.52 Kb.


Key words:

glibenclamide, glyburide, high performance liquid chromatography, validation, cleaning validation, traces, detection limit, quantization limit.

ABSTRACT

Objective: to submit a selective analytical method for quantization of glibenclamide in cleaning samples of pharmaceutical equipment using high performance liquid chromatography.
Methods: the mobile phase consisted of an equal mixing of acetonitrile/phosphate buffer KH2PO4; with 0.037 mol/L concentration pH 5.25 and flow of 1.5 mL/min, in a Nucleosil 100 C8 column. Glibenclamide was injected with progesterone as internal standard and using an UV detector= 230 nm.
Results: the method was linear in the 0.4-150 μg/mL concentration interval having a detection and quantization limits of 10 and 40 ng/mL respectively. It was specific to analyte when placebo is present, to degradation products and to other active ingredients. Possible interferences with the proposed method was considered for captopril, chlortalidone, dexametasone, diphenhydramin HCl, digoxine, 8- chlortheophylline, diphenhydramina HCl, phenobarbital, haloperidol, hydrochlorothia zide, fumaric acid, ketotifen, metoclopramide HCl, piridoxine HCl, piroxicam, prednisone and nifedipine, On the other hand, ibuprofen, indometacin, trifluoperazine HCl, thioridazine HCl and imipramine were identified as interferences in the procedure at concentration figures close to 10 μg/mL.
Conclusions: the present method is sensitive, quick and selective for the evaluation of residues of active pharmaceutical principle glibenclamide in tablet production equipment after a swap sampling and it could be potentially used in case of crosscontamination of glibenclamide and other drugs already described.


REFERENCES

  1. Guide to cleaning validation in API plants, cleaning validation in active pharmaceutical ingredient manufacturing plants. Active Pharmaceutical Ingredients Comité 1999; September: 7-20. Available from: http://apic.cefic.org/pub/4CleaningVal9909.pdf

  2. Venkatesh P. Simultaneous determination of six antidiabetic drugs: glibenclamide, glicazide, glipizide, pioglitazone, repaglinide and rosiglitazone: development of a novel CLAR method for use in the analysis of pharmaceutical formulations and its application to human plasma assay. Biomed Chromatography. 2006;20(10):1043-8.

  3. Kumasaka K. Screening and quantitative analysis for sulphonylurea-type oral antidiabetic agents in adulterated health food using thin layer chromatography and high performance liquid chromatography. J Health Sci. 2005;51:453-60.

  4. Carabias-Martínez R. Simultaneous determination of phenyl and sufonylureas in water by solid phase extraction and liquid chromatography with diode array or mass spectrometric detection. Analytica Chemica Acta. 2004;517:71-9.

  5. Pelander A. Toxicological screening with formula based metabolite identification by liquid chromatography/time of flight mass spectrometry. Analytical Chemistry. 2003;75:5710-18.

  6. Prabu LS, Suriyaprakash TNK. Cleaning validation and its importance in pharmaceutical industry. Pharma Times. 2010;42(7):21-5.

  7. PDA Tecnical Report No 29: Points to consider for cleaning validation. International association for Pharmaceutical Science and technology, Draf, March, 1998. Available from: http://www.pharmanet.com.br/pdf/tr29-002.pdf

  8. LeBlanc DA. Cleaning Validation Teccnologies. Available from: http://www.cleaningvalidation.com/

  9. López Marzo AM, Pierre Marzo RA. Establecimiento del límite aceptable para el residuo de limpieza en los equipos de producción de la industria farmacéutica. Rev Cubana Farm 2005;39(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152005000300010&lng=es&nrm=iso

  10. Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme. Available from: http://www.picscheme.org/

  11. Fourman GL, Mullen MV. Determining Cleaning Validation Acceptance Limits for Pharmaceutical Manufacturing Operations. Pharm Technol. 1993;17(4):54-60.

  12. Quattrochi O, Abelaira S. Introducción a la HPLC. Buenos Aires: Artes Gráficas; 1992.

  13. Harmonized guidelines for single-laboratory validation of methods of analysis. Pure Applied Chemistry. 2002;74:835-55.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Farm. 2012;46